Modeling Large Vessel Occlusion Stroke for the Evaluation of Endovascular Therapy According to Thrombus Composition.
Modeling Large Vessel Occlusion Stroke for the Evaluation of Endovascular Therapy According to Thrombus Composition.
复制标题
DOI:
10.3389/fneur.2021.815814
复制
发表时间:
2021
影响因子:
3.4
通讯作者:
Désilles JP
中科院分区:
文献类型:
--
作者:
Freiherr von Seckendorff A;Delvoye F;Levant P;Solo Nomenjanahary M;Ollivier V;Bourrienne MC;Di Meglio L;Piotin M;Escalard S;Maier B;Hebert S;Smajda S;Redjem H;Mazighi M;Blanc R;Ho-Tin-Noé B;Désilles JP
More than 40% of endovascular therapy (EVT) fail to achieve complete reperfusion of the territory of the occluded artery in patients with acute ischemic stroke (AIS). Understanding factors influencing EVT could help overcome its limitations. Our objective was to study the impact of thrombus cell composition on EVT procedures, using a simulation system for modeling thrombus-induced large vessel occlusion (LVO) in flow conditions. In an open comparative trial, we analyzed the behavior of size-standardized platelet-rich and red blood cells (RBC)-rich thrombi during simulated stent retriever-mediated EVT procedures. Sixteen simulated EVT procedures were performed (8 RBC- vs. 8 platelet-rich thrombi). Platelet-rich thrombi were associated with a higher number of stent retriever passes (p = 0.03) and a longer procedure duration (p = 0.02) compared to RBC-rich thrombi. Conversely, RBC-rich thrombi released more embolic fragments than platelet-rich thrombi (p = 0.004). Both RBC-rich and platelet-rich thrombi underwent drastic compaction after being injected into the in vitro circulation model, and histologic analyses showed that these EVT-retrieved thrombi displayed features comparable to those previously observed in thrombi from patients with AIS patients having LVO, including a marked structural dichotomy between RBC- and platelet-rich areas. Our results show that the injection of in vitro-produced thrombi in artificial cerebrovascular arterial networks is suitable for testing recanalization efficacy and the risk of embolization of EVT devices and strategies in association with thrombus cell composition.
登录
查看更多内容
影响因子:
8.3
作者:
Jolugbo P;Ariëns RAS
通讯作者:
Ariëns RAS
影响因子:
3.5
作者:
Kaesmacher, J.;Boeckh-Behrens, T.;Huber, T.
通讯作者:
Huber, T.
DOI:
10.1161/atvbaha.115.306537
发表时间:
2016-04-01
影响因子:
8.7
作者:
Swieringa, Frauke;Baaten, Constance C. F. M. J.;van der Meijden, Paola E. J.
通讯作者:
van der Meijden, Paola E. J.
影响因子:
1.9
作者:
Maekawa, Kota;Shibata, Masunari;Miya, Fumitaka
通讯作者:
Miya, Fumitaka
DOI:
10.1055/a-0998-4246
发表时间:
2020-03-01
影响因子:
1.8
作者:
Madjidyar, Jawid;Vidal, Lorena Pineda;Jansen, Olav
通讯作者:
Jansen, Olav